Apolipoprotein A-V concentration in preterm infants

van der Vliet, 2001, Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration, J Biol Chem, 276, 44512, 10.1074/jbc.M106888200 Pennacchio, 2001, An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing, Science, 294, 169, 10.1126/science.1064852 Schaap, 2004, ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis, J Biol Chem, 279, 27941, 10.1074/jbc.M403240200 van der Vliet, 2002, Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice, Biochem Biophys Res Commun, 295, 1156, 10.1016/S0006-291X(02)00808-2 Priore Oliva, 2005, Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia, Arterioscler Thromb Vasc Biol, 25, 411, 10.1161/01.ATV.0000153087.36428.dd Zhao, 2010, Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects, BMC Med Genet, 11, 120, 10.1186/1471-2350-11-120 Kisfali, 2008, Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians, Circ J, 72, 40, 10.1253/circj.72.40 Grallert, 2007, APOA5 variants and metabolic syndrome in Caucasians, J Lipid Res, 48, 2614, 10.1194/jlr.M700011-JLR200 Grosskopf, 2005, Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants, Arterioscler Thromb Vasc Biol, 25, 2573, 10.1161/01.ATV.0000186189.26141.12 Hyun, 2009, Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men, Atherosclerosis, 205, 568, 10.1016/j.atherosclerosis.2008.12.035 Hirano, 2007, Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease, Metabolism, 56, 462, 10.1016/j.metabol.2006.11.002 Huang, 2009, Association of plasma apolipoprotein AV with lipid profiles in patients with acute coronary syndrome, Atherosclerosis, 204, e99, 10.1016/j.atherosclerosis.2008.11.019 Fujita, 2008, Low-density lipoprotein profile changes during the neonatal period, J Perinatol, 28, 335, 10.1038/jp.2008.8 Yonezawa, 2009, Very low-density lipoprotein in the cord blood of preterm neonates, Metabolism, 58, 704, 10.1016/j.metabol.2009.02.004 Ogawa, 1998, Birth size standards by gestational age for Japanese neonates, Acta Neonatologica Japnonica, 34, 624 Okazaki, 2005, Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography, Arterioscler Thromb Vasc Biol, 25, 578, 10.1161/01.ATV.0000155017.60171.88 Ishihara, 2005, A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration, J Lipid Res, 46, 2015, 10.1194/jlr.D500018-JLR200 Kobayashi, 1993, Lipoprotein lipase mass and activity in severe hypertriglyceridemia, Clin Chim Acta, 216, 113, 10.1016/0009-8981(93)90144-S Averna, 1991, Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns, Biol Neonate, 60, 187, 10.1159/000243407 Cardona, 2009, The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study, Atherosclerosis, 206, 148, 10.1016/j.atherosclerosis.2009.02.024 Perez-Martinez, 2009, Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states, Am J Clin Nutr, 89, 391, 10.3945/ajcn.2008.26363 Moreno-Luna, 2007, Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population, J Clin Endocrinol Metab, 92, 2280, 10.1210/jc.2006-1802 Jang, 2004, The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men, Am J Clin Nutr, 80, 832, 10.1093/ajcn/80.4.832 Shu, 2007, Apolipoprotein A-V association with intracellular lipid droplets, J Lipid Res, 48, 1445, 10.1194/jlr.C700002-JLR200 Abe, 2009, Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children, J Atheroscler Thromb, 16, 121, 10.5551/jat.E356 Dallinga-Thie, 2006, Plasma apolipoprotein A5 and triglycerides in type 2 diabetes, Diabetologia, 49, 1505, 10.1007/s00125-006-0261-0 Hahne, 2008, Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans, J Intern Med, 264, 452, 10.1111/j.1365-2796.2008.01987.x Gesteiro, 2011, Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates, Eur J Pediatr, 170, 1551, 10.1007/s00431-011-1473-y